Search Results - Vanaja Kumar

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Stratifying low level Isoniazid resistance using additional intermediate drug concentration by Rajagopalan Lakshmi, Ranjani Ramachandran, A Syam Sundar, Fathima Rahman, Vanaja Kumar

    Published in International Journal of Mycobacteriology (2014-01-01)
    Get full text
    Article


  2. 2

    Performance indicators of fluorescence microscopy for sputum samples in pulmonary tuberculosis by N Selvakumar, A Syam Sunder, M Gomathi Sekar, C Ponnuraja, Vanaja Kumar

    Published in International Journal of Mycobacteriology (2012-01-01)
    Get full text
    Article


  3. 3

    Retrieval of Mycobacterium tuberculosis cultures suspended in phosphate buffered saline by V N. Azger Dusthackeer, P Nagarajan, Dasarathi Das, Vanaja Kumar, N Selvakumar

    Published in International Journal of Mycobacteriology (2012-01-01)
    Get full text
    Article


  4. 4

    Optimization of the conventional minimum inhibitory concentration method for drug susceptibility testing of ethionamide by Rajagopalan Lakshmi, Ranjani Ramachandran, A Syam Sundar, Fathima Rehman, Golla Radhika, Vanaja Kumar

    Published in International Journal of Mycobacteriology (2013-01-01)
    Get full text
    Article


  5. 5

    Quality indicators in a mycobacteriology laboratory supporting clinical trials for pulmonary tuberculosis by N Selvakumar, K Silambuchelvi, M Gomathi Sekar, A Syam Sunder, S Anbarasu, V Banu Rekha, C Ponnuraja, Vanaja Kumar

    Published in International Journal of Mycobacteriology (2012-01-01)
    Get full text
    Article


  6. 6

    High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India. by N Selvakumar, Vanaja Kumar, S Balaji, S Prabuseenivasan, R Radhakrishnan, Gomathi Sekar, V Chandrasekaran, T Kannan, Aleyamma Thomas, S Arunagiri, Puneet Dewan, Soumya Swaminathan

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  7. 7

    In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor. by Rajesh Mondal, Azger Dusthackeer V N, Palaniyandi Kannan, Amit Kumar Singh, Kannan Thiruvengadam, Radhakrishnan Manikkam, Shainaba A S, Mahizhaveni Balasubramanian, Padmasini Elango, Sam Ebenezer Rajadas, Dinesh Bharadwaj, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Hemanth Kumar A K, Manjula Singh, Shripad Patil, Jaleel U C A, Mukesh Doble, Balagurunathan R, Srikanth Prasad Tripathy, Vanaja Kumar

    Published in PLoS ONE (2023-01-01)
    Get full text
    Article


  8. 8

    Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients. by Mohideen S Jawahar, Vaithilingam V Banurekha, Chinnampedu N Paramasivan, Fathima Rahman, Rajeswari Ramachandran, Perumal Venkatesan, Rani Balasubramanian, Nagamiah Selvakumar, Chinnaiyan Ponnuraja, Allaudeen S Iliayas, Navaneethapandian P Gangadevi, Balambal Raman, Dhanaraj Baskaran, Santhanakrishnan R Kumar, Marimuthu M Kumar, Victor Mohan, Sudha Ganapathy, Vanaja Kumar, Geetha Shanmugam, Niruparani Charles, Murugesan R Sakthivel, Kannivelu Jagannath, Chockalingam Chandrasekar, Ramavaram T Parthasarathy, Paranji R Narayanan

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


Search Tools: